RO5313534

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Alzheimer's DiseaseHealthy Volunteer

Phase 1

A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State Memantine

CompletedNCT01196065

Hoffmann-La RocheHealthy Volunteer

Start: 2010-09-30End: 2010-11-30Updated: 2016-11-02

Phase 2

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

CompletedNCT00884507

Hoffmann-La RocheAlzheimer's Disease

Start: 2009-05-31End: 2010-11-30Updated: 2016-11-02